公开(公告)号：US20230112641A1

公开(公告)日：2023-04-13

申请号：US17904621

申请日：2021-03-11

Applicant: ABBOTT LABORATORIES

Inventor： Suzette PEREIRA ,  Ricardo RUEDA ,  Vadivel GANAPATHY

IPC: A61K31/19 ,  A61K47/42 ,  A61K47/26 ,  A61K47/44 ,  A61P1/12 ,  A61P29/00

Abstract: A method of treating diarrhea or an inflammatory condition of the gut in a subject comprises administering a therapeutically effective amount of beta-hydroxy-beta-methylbutyrate (HMB) or a salt thereof to a subject in need thereof. A method of treating secretory diarrhea in a subject comprises administering a therapeutically effective amount of HMB or a salt thereof to a subject exhibiting one or more of the following symptoms: loss of fluids from the gut, loss of electrolytes from the gut, dehydration, or inflammation of the intestinal tract.

公开(公告)号：US20200163370A1

公开(公告)日：2020-05-28

申请号：US16627831

申请日：2018-07-24

Applicant: Abbott Laboratories

Inventor： Gaurav PATEL ,  Normanella DEWILLE ,  Suzette PEREIRA ,  Rockendra GUPTA

IPC: A23L33/00 ,  A23L33/19 ,  A23L33/12 ,  A23L2/60 ,  A23L33/165 ,  A23L2/66 ,  A23L33/125 ,  A23L33/105 ,  A23L33/185 ,  A23L2/56

Abstract: A sterilized liquid nutritional composition has an off-white color and a pH of from about 6 to 7.5 and comprises a source of protein, a source of fat, a source of carbohydrate, green tea extract comprising epigallocatechin gallate (EGCg), and an insoluble source of iron comprising at least one of ferric orthophosphate and ferric pyrophosphate. The liquid nutritional composition comprises, per 237 ml serving, from about 50 to 500 mg green tea extract and from about 6 to 60 mg ferric orthophosphate and/or ferric pyrophosphate, and has a Hunter L value not less than 60.

公开(公告)号：US20230255928A1

公开(公告)日：2023-08-17

申请号：US17996793

申请日：2021-04-23

Applicant: Abbott Laboratories

Inventor： Suzette PEREIRA ,  Ricardo RUEDA CABRERA ,  Vikkie MUSTAD

IPC: A61K31/353 ,  A61P7/00 ,  A23L33/105 ,  A23L33/00 ,  A23L33/19 ,  A23L33/185 ,  A23L33/175 ,  A23L33/125 ,  A23L33/115

CPC classification number: A61K31/353 ,  A61P7/00 ,  A23L33/105 ,  A23L33/40 ,  A23L33/19 ,  A23L33/185 ,  A23L33/175 ,  A23L33/125 ,  A23L33/115

Abstract: Methods of increasing microvascular blood flow in the muscle of a human subject comprise orally administering about 100 to about 800 mg cocoa flavanols per day in a nutritional composition comprising at least one source of protein, to a subject in need of increased microvascular blood flow in the muscle.